Fatty Acid and Protein Metabolism (1D)

Help Questions

MCAT Biological and Biochemical Foundations of Living Systems › Fatty Acid and Protein Metabolism (1D)

Questions 1 - 10
1

A patient with exercise intolerance is found to carry a homozygous missense variant in the gene encoding medium-chain acyl-CoA dehydrogenase (MCAD), a mitochondrial enzyme used during beta-oxidation of medium-chain fatty acids. During a supervised 18-hour fast, plasma measurements were obtained.

Based on the experimental setup, what is the most likely effect of the mutation on metabolism?

Increased urea production because MCAD normally catalyzes oxidative deamination of amino acids during fasting

Decreased blood glucose because beta-oxidation directly consumes glucose as a co-substrate in the mitochondrial matrix

Decreased ketone body production due to reduced acetyl-CoA generation from beta-oxidation, with increased reliance on glucose

Increased ketone body production due to diversion of fatty acids toward cytosolic beta-oxidation

Explanation

This question tests understanding of beta-oxidation defects and their metabolic consequences during fasting. MCAD catalyzes the first dehydrogenation step in beta-oxidation of medium-chain fatty acids, and its deficiency impairs the breakdown of these fatty acids into acetyl-CoA. During fasting, reduced acetyl-CoA production from beta-oxidation leads to decreased ketone body synthesis in the liver, forcing increased reliance on glucose for energy. The correct answer A accurately describes this metabolic shift with reduced ketogenesis and increased glucose utilization. Choice B incorrectly suggests increased ketone production, which is impossible when beta-oxidation is impaired since acetyl-CoA is the substrate for ketogenesis. When evaluating metabolic defects, trace the pathway from substrate to product to predict downstream effects.

2

A patient has a mutation that reduces activity of medium-chain acyl-CoA dehydrogenase (MCAD). During an overnight fast, plasma acylcarnitine profiling shows elevated medium-chain acylcarnitines, while urinary ketones are low despite hypoglycemia.

Based on the experimental setup, what is the most likely effect of the mutation on metabolism?

Increased gluconeogenesis from fatty acids compensates, so ketones decrease because glucose rises

Enhanced peroxisomal oxidation increases acetyl-CoA export to cytosol, increasing ketone production

Impaired mitochondrial $b2$-oxidation reduces acetyl-CoA supply for ketogenesis, lowering ketone production during fasting

Blocked fatty acid synthesis decreases malonyl-CoA, directly causing hypoglycemia via reduced glycogen breakdown

Explanation

This question tests understanding of fatty acid metabolism, specifically medium-chain acyl-CoA dehydrogenase (MCAD) deficiency's effect on β-oxidation and ketogenesis. MCAD is crucial for mitochondrial β-oxidation of medium-chain fatty acids, producing acetyl-CoA for ketogenesis during fasting. The mutation leads to elevated acylcarnitines, low urinary ketones, and hypoglycemia, indicating blocked oxidation and reduced ketone production. Choice A is correct because impaired β-oxidation limits acetyl-CoA for ketogenesis, causing hypoketotic hypoglycemia. Choice B is incorrect as it suggests enhanced peroxisomal oxidation increasing ketones, but MCAD is mitochondrial and deficiency reduces overall oxidation. In similar inborn error cases, link enzyme defect to substrate accumulation and downstream fuel shortages. Check for compensatory pathways like peroxisomal oxidation but note their limitations.

3

Investigators measure initial velocity of purified human alanine aminotransferase (ALT) at varying alanine concentrations with $b1$-ketoglutarate held constant. NADH-coupled detection is used to quantify pyruvate formation. Initial rates plateau at high alanine.

Data (alanine, mM b2 v0, bcM/min):

0.2 b2 8

0.5 b2 18

1.0 b2 30

2.0 b2 40

5.0 b2 46

Which outcome is most consistent with the data on enzyme activity?

ALT activity will continue to rise linearly with alanine concentration because transamination is not saturable

ALT catalyzes alanine oxidation in the cytosol, so maximal rate requires mitochondrial alanine transport

ALT is saturated with alanine near 5 mM, so further increases in alanine would minimally change $v_0$ at fixed $b1$-ketoglutarate

Increasing alanine will decrease $v_0$ by shifting equilibrium toward alanine, reducing pyruvate formation

Explanation

This question tests understanding of protein metabolism, focusing on enzyme kinetics in amino acid transamination by alanine aminotransferase (ALT). ALT catalyzes the reversible transfer of an amino group from alanine to α-ketoglutarate, producing pyruvate and glutamate, following Michaelis-Menten kinetics with saturation at high substrate levels. The data show initial velocity plateauing at higher alanine concentrations with fixed α-ketoglutarate, indicating enzyme saturation. Choice D is correct because ALT becomes saturated near 5 mM alanine, so further increases yield minimal changes in v0, consistent with saturable kinetics. Choice B is incorrect as it assumes non-saturable, linear kinetics, ignoring the enzyme's finite active sites and typical hyperbolic behavior. For similar kinetics problems, plot or visualize the data to check for hyperbolic saturation and recall that enzymes approach Vmax at high substrate. Also, distinguish between substrates to identify which is variable and potentially limiting.

4

In a human study, insulin is infused while maintaining euglycemia. Liver biopsies (obtained for clinical reasons) show increased acetyl-CoA carboxylase (ACC) activity and increased malonyl-CoA concentration compared with pre-infusion. Plasma ketone bodies decrease.

What conclusion can be drawn about the role of insulin in fat storage?

Insulin decreases malonyl-CoA, which activates CPT1 and increases ketone body formation

Insulin increases malonyl-CoA, which tends to reduce mitochondrial fatty acid entry and oxidation, favoring lipid storage over ketogenesis

Insulin suppresses lipogenesis by inhibiting ACC, lowering malonyl-CoA and increasing TAG breakdown

Insulin increases ketone bodies by activating HSL in adipose, increasing FFA delivery to liver

Explanation

This question tests understanding of fatty acid metabolism, particularly insulin's regulation of lipogenesis and ketogenesis via malonyl-CoA. Insulin activates acetyl-CoA carboxylase (ACC), increasing malonyl-CoA, which inhibits CPT1 and mitochondrial fatty acid oxidation, reducing ketogenesis. Biopsies show increased ACC and malonyl-CoA with decreased plasma ketones, aligning with insulin's suppression of oxidation. Choice D is correct as elevated malonyl-CoA reduces fatty acid entry and ketogenesis, favoring storage. Choice B is incorrect because insulin increases, not decreases, malonyl-CoA, inhibiting CPT1. For regulatory studies, trace hormone effects on intermediates like malonyl-CoA and correlate with outcomes like ketone levels. Distinguish between acute and chronic insulin effects on liver metabolism.

5

An enzyme kinetics experiment measures initial velocity of glutamate dehydrogenase (GDH) in isolated human liver mitochondria while varying glutamate concentration; NAD+ is saturating. Ammonia production is quantified.

Data (glutamate, mM b2 v0, nmol NH3/min):

0.5 b2 12

1.0 b2 20

2.0 b2 30

4.0 b2 36

8.0 b2 39

Which outcome is most consistent with the data on enzyme activity?

GDH is cytosolic, so mitochondrial measurements cannot show saturation behavior

At high glutamate, GDH approaches a maximum rate, so additional glutamate produces diminishing increases in $v_0$

Increasing glutamate will linearly increase $v_0$ indefinitely because deamination is diffusion-limited

GDH rate should decrease at high glutamate because glutamate is a product, not a substrate, of GDH

Explanation

This question tests understanding of protein metabolism, focusing on kinetics of glutamate dehydrogenase (GDH) in amino acid catabolism. GDH catalyzes oxidative deamination of glutamate to α-ketoglutarate and ammonia, exhibiting saturable kinetics with respect to glutamate. The data show v0 increasing but plateauing at higher glutamate, consistent with Michaelis-Menten behavior. Choice D is correct as GDH approaches maximum rate at high substrate, yielding diminishing v0 increases. Choice B is incorrect because glutamate is the substrate, not product, so high levels drive forward reaction. For mitochondrial enzyme kinetics, ensure cofactors like NAD+ are saturating and monitor appropriate products. Recall GDH's role linking amino acid and carbohydrate metabolism.

6

A lab deprives cells of phenylalanine for 6 hours and measures secretion of a phenylalanine-rich plasma protein from hepatocytes. Intracellular mRNA levels for the protein are unchanged, but secreted protein decreases to 55% of control.

Which interpretation best explains the data?

Phenylalanine deprivation increases secretion because fewer aromatic residues reduce folding time

Secretion decreases because phenylalanine is produced from tyrosine in humans, causing toxic tyrosine depletion

Secretion decreases because phenylalanine is required for transcription initiation, so mRNA must have fallen

Amino acid limitation reduces translation efficiency for proteins requiring that amino acid, lowering output despite unchanged mRNA

Explanation

This question tests understanding of protein metabolism, focusing on phenylalanine deprivation's impact on secretion of phenylalanine-rich proteins. Deprivation limits translation of proteins requiring phenylalanine, reducing secretion without affecting mRNA levels. Decreased secreted protein despite stable mRNA indicates translational bottleneck. Choice A is correct because amino acid limitation reduces translation efficiency for dependent proteins. Choice C is incorrect as phenylalanine isn't required for transcription; effect is post-transcriptional. For secretion studies, compare mRNA and protein levels to localize effects. Note essential amino acids' roles in limiting synthesis of specific proteins.

7

A patient has recurrent fasting intolerance. Whole-exome sequencing identifies a variant that increases malonyl-CoA levels in liver by constitutively activating acetyl-CoA carboxylase (ACC). During fasting, plasma ketones are low despite elevated FFAs.

Based on the experimental setup, what is the most likely effect of this alteration on metabolism?

Elevated malonyl-CoA activates CPT1, increasing hepatic fatty acid oxidation and ketogenesis

Elevated malonyl-CoA blocks glycolysis, forcing acetyl-CoA into ketogenesis and raising ketones

Elevated malonyl-CoA directly stimulates hormone-sensitive lipase, increasing adipose lipolysis and ketones

Elevated malonyl-CoA tends to inhibit mitochondrial fatty acid entry, reducing hepatic $b2$-oxidation and ketone production during fasting

Explanation

This question tests understanding of fatty acid metabolism, particularly elevated malonyl-CoA's effect on ketogenesis. Malonyl-CoA inhibits CPT1, reducing mitochondrial fatty acid entry and β-oxidation, leading to low ketones despite high FFAs in fasting. The variant constitutively activates ACC, raising malonyl-CoA and causing fasting intolerance with hypoketosis. Choice A is correct as elevated malonyl-CoA inhibits entry, reducing oxidation and ketogenesis. Choice B is incorrect because malonyl-CoA inhibits, not activates, CPT1. For regulatory variants, predict effects on downstream pathways like oxidation. Correlate with clinical symptoms like fasting intolerance to confirm.

8

A patient with episodic rhabdomyolysis is found to have a mutation reducing muscle carnitine uptake (systemic carnitine deficiency). During prolonged exercise, plasma shows elevated long-chain acylcarnitines are low, while long-chain acyl-CoA accumulates in muscle biopsy.

Based on the experimental setup, what is the most likely effect of the mutation on metabolism?

Increased mitochondrial import of long-chain fatty acids raises acetyl-CoA, causing excessive ketone production in muscle

Reduced carnitine availability limits transport of long-chain fatty acids into mitochondria, decreasing $b2$-oxidation and ATP generation during exercise

Fatty acid oxidation shifts to the cytosol, preserving ATP yield while lowering acyl-CoA accumulation

Carnitine deficiency primarily blocks amino acid transamination, reducing urea formation and causing hyperammonemia during exercise

Explanation

This question tests understanding of fatty acid metabolism, specifically carnitine deficiency's impact on muscle β-oxidation during exercise. Carnitine is required for long-chain fatty acid transport into mitochondria via CPT systems; deficiency limits this, reducing ATP from oxidation and causing acyl-CoA accumulation. Elevated plasma acylcarnitines and muscle acyl-CoA during exercise indicate blocked transport and impaired energy production. Choice C is correct because reduced carnitine limits mitochondrial entry, decreasing β-oxidation and ATP. Choice B is incorrect as it suggests increased import and ketones, opposite to deficiency effects. In transport defect cases, look for substrate accumulation patterns to confirm blockade. Consider tissue-specific effects, like muscle fatigue in exercise.

9

A team examines the effect of leucine deprivation on protein synthesis in human skeletal muscle cells. Cells are incubated for 4 hours in complete media or leucine-free media. ATP levels remain stable, but phosphorylation of eIF2b1 (a translation initiation regulator) increases in leucine-free conditions.

Measured outcome: global protein synthesis (normalized)

  • Complete: 1.0
  • Leucine-free: 0.60

Which interpretation best explains the reduction in protein synthesis?

Leucine deprivation has no effect because leucine is nonessential and can be synthesized from pyruvate

Leucine deprivation increases protein synthesis by diverting acetyl-CoA away from fatty acid oxidation

Protein synthesis decreases because peptide bond formation requires NADH, which is depleted only when leucine is absent

Amino acid limitation triggers signaling that suppresses translation initiation/elongation, reducing global protein synthesis

Explanation

This question tests understanding of protein metabolism, particularly how leucine deprivation affects translation regulation. Leucine, an essential amino acid, signals through mTOR to promote translation initiation; its absence increases eIF2α phosphorylation, suppressing global protein synthesis. In leucine-free media, synthesis decreases with elevated eIF2α phosphorylation and stable ATP, indicating regulatory inhibition. Choice A is correct because amino acid limitation triggers signaling that suppresses translation, reducing synthesis. Choice C is incorrect as leucine is essential and cannot be synthesized de novo in humans. To evaluate similar deprivations, check signaling markers like eIF2α and energy levels to pinpoint mechanisms. Differentiate essential from nonessential amino acids in human metabolism.

10

To probe how amino acid availability constrains protein synthesis, researchers cultured primary human myotubes for 6 hours in complete medium or medium lacking leucine. They then added puromycin for 10 minutes and quantified puromycin incorporation into nascent polypeptides (a proxy for translation rate). Total cellular mRNA levels for a housekeeping gene were unchanged between conditions.

Which outcome is most consistent with the data on enzyme activity (translation machinery function) under leucine deprivation?

Increased puromycin incorporation because leucine depletion stimulates global translation to compensate for missing amino acids

No change in puromycin incorporation because ribosomes can substitute isoleucine for leucine during elongation

Increased puromycin incorporation because leucine deprivation directly increases aminoacyl-tRNA synthetase catalytic rate

Decreased puromycin incorporation because limited charged Leu-tRNA reduces elongation despite unchanged mRNA abundance

Explanation

This question tests understanding of protein metabolism regulation, specifically how amino acid availability controls translation through charged tRNA levels. Leucine is an essential amino acid that must be attached to its cognate tRNA by leucyl-tRNA synthetase for incorporation during translation elongation. When leucine is depleted, the pool of charged Leu-tRNA decreases, causing ribosomes to stall at leucine codons during elongation, thereby reducing overall translation rate despite unchanged mRNA levels. Puromycin incorporation serves as a readout for active translation because it mimics aminoacyl-tRNA and terminates growing peptide chains. Choice A is incorrect because amino acid deprivation typically suppresses, not stimulates, global translation through mechanisms like GCN2 kinase activation and eIF2α phosphorylation. To assess translation regulation, distinguish between changes in mRNA abundance versus ribosome activity, and remember that amino acid availability affects elongation through charged tRNA pools.

Page 1 of 6